spironolactone has been researched along with carbon tetrachloride in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Davis, DC; Gillette, JR; Sasame, HA | 1 |
| Mihas, AA; Saccomani, G; Spenney, JG | 1 |
| Lai, W; Li, S; Li, X; Meng, Y; Wu, P; Yang, X | 1 |
| CASCIO, G; PALAZZOADRIANO, M | 1 |
| Asadian, P; Crawford, DH; Fletcher, LM; Khlentzos, AM; Li, P; Liu, X; Roberts, MS; Robertson, TA; Thorling, CA; Zou, YH | 1 |
1 review(s) available for spironolactone and carbon tetrachloride
| Article | Year |
|---|---|
Cytochrome P-450 and its role in drug metabolism.
Topics: Adrenalectomy; Animals; Carbon Tetrachloride; Cytochromes; Dealkylation; Deamination; Enzyme Induction; Female; Glucocorticoids; Hydroxylation; Male; Mice; Microsomes, Liver; NADP; Oxidation-Reduction; Oxidoreductases; Oxygen Consumption; Pharmaceutical Preparations; Phenobarbital; Phospholipids; Polycyclic Compounds; Pseudomonas; Rats; Sex Factors; Spectrum Analysis; Spironolactone; Ultraviolet Rays | 1972 |
7 other study(ies) available for spironolactone and carbon tetrachloride
| Article | Year |
|---|---|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
LSA--a new liver-specific antigen in the rat. II: Immunological and biological properties.
Topics: Animals; Bile Acids and Salts; Carbon Tetrachloride; Chromatography; Counterimmunoelectrophoresis; Embryonic and Fetal Development; Female; Galactosamine; Guinea Pigs; Immunodiffusion; Iodine Radioisotopes; Isoantibodies; Isoantigens; Liver; Mice; Mice, Inbred BALB C; Phylogeny; Propylthiouracil; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Spironolactone; Vitamin E | 1994 |
CYP11B2 expression in rat liver and the effect of spironolactone on hepatic fibrogenesis.
Topics: Animals; Carbon Tetrachloride; Cytochrome P-450 CYP11B2; Gene Expression; In Situ Hybridization; Liver; Liver Cirrhosis; Male; Microscopy, Electron; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Spironolactone | 2000 |
[CHARACTERIZATION OF THE DIURETIC EFFECT OF COUMARIN-3-GLYOXYLIC ALDEHYDE].
Topics: Aldehydes; Aldosterone; Body Fluids; Carbon Tetrachloride; Chlorothiazide; Coumarins; Diuretics; Electrolytes; Pharmacology; Rats; Research; Spironolactone; Urine | 1963 |
Liver fibrosis impairs hepatic pharmacokinetics of liver transplant drugs in the rat model.
Topics: Animals; Bile Ducts, Intrahepatic; Carbon Tetrachloride; Extracellular Space; Furosemide; Liver; Liver Cirrhosis; Liver Transplantation; Male; Metoprolol; Models, Biological; Omeprazole; Organ Size; Oxygen Consumption; Pharmaceutical Preparations; Pharmacokinetics; Propranolol; Rats; Rats, Wistar; Spironolactone; Transplantation Conditioning; Water | 2010 |